SUREFIRE RESOURCES NL — Director's Dealing 2007

Mar 25, 2007

Appendix 3Y

Rule 3.19A.2

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/9/2001.

Name of entity: Genesis Biomedical Limited
ABN: 48 083 274 024

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Mr Donald Lawrence Valentino
Date of last notice	12 December 2006

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest	Transfer of control from Donald Lawrence
	Valentino
Nature of indirect interest	Transfer of control of:
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevantinterest.	1,820,000 Fully Paid Ordinary Shares
	900,000 Options $0.03, 30 November 2010
	TO: Paul Matthew Valentino
	David Peter Valentino
	FROM: Mr Donald Lawrence Valentino
Date of change of control	23 March 2007
No. of securities held prior to change	6,618,267 Fully Paid Ordinary Shares
	5,398,267Options$0.03,3November 2010
Class	Ordinary Shares
	Options $0.03, 30 November 2010
Number of securities for which control has been	1,820,000 Fully Paid Ordinary Shares
transferred	900,000 Options $0.03, 30 November 2010
Number disposed	Nil
Value/Consideration	Nil, no change of registered holder
Note: If consideration is non-cash, provide details and estimatedvaluation

+ See chapter 19 for defined terms.

No. of securities controlled after change	4,798,267 Fully Paid Ordinary Shares4,498,267Options$0.03,30November2010
Nature of changeExample: on-market trade, off-market trade, exercise of options, issue ofsecurities under dividend reinvestment plan, participation in buy-back	Reversal of previous temporarycontrolreverting back to registered holders. (referAppendix 3Y lodged 12/12/06)

Part 2 - Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract	Nil
Nature of interest
Name of registered holder(if issued securities)
Date of change
No. and class of securities towhich interest related prior tochangeNote: Details are only required for a contract in relationto which the interest has changed
Interest acquired
Interest disposed
Value/ConsiderationNote: If consideration is non-cash, provide details andan estimated valuation.
Interest after change

$+$ See chapter 19 for defined terms.

Appendix 3Y

Rule 3.19A.2

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/9/2001.

Name of entity: Genesis Biomedical Limited
IABN: 48 083 274 024

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Mr Russell Black
Date of last notice	3 March 2006

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.	Via the following registered holders:Amber Management Pty LtdGoldfinch Black Investment House Pty Ltd
Date of change	20 & 23 March 2007
No. of securities held prior to change	2,262,500 Fully Paid Ordinary Shares
Class	Ordinary SharesOptions $0.03, 30 November 2010
Number acquired	537,500 Fully Paid Ordinary Shares400,000 Options $0.03, 30 November 2010
Number disposed	Nil
Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation	$25,175.00

+ See chapter 19 for defined terms.

No. of securities held after change	2,800,000 Fully Paid Ordinary Shares400,000Options$0.03,30November2010
Nature of changeExample: on-market trade, off-market trade, exercise of options, issue ofsecurities under dividend reinvestment plan, participation in buy-back	On Market Purchase

Part 2 - Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract	Nil
Nature of interest
Name of registered holder(if issued securities)
Date of change
No. and class of securities towhich interest related prior tochangeNote: Details are only required for a contract in relationto which the interest has changed
Interest acquired
Interest disposed
Value/ConsiderationNote: If consideration is non-cash, provide details andan estimated valuation.
Interest after change

$+$ See chapter 19 for defined terms.